Cobalt and antimony: Genotoxicity and carcinogenicity

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 533, Issue 1-2, 2003, Pages 135-152

  De Boeck, Marlies ^a   Kirsch Volders, Micheline ^a   Lison, Dominique ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Antimony; Carcinogenicity; Cobalt; Genotoxicity

Indexed keywords

ANTIMONY; COBALT; DNA;

ANEUPLOIDY; APOPTOSIS; CARCINOGENICITY; CELL TRANSFORMATION; CHROMOSOME ABERRATION; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENOTOXICITY; HUMAN; IN VITRO STUDY; MAMMAL CELL; MICRONUCLEUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SISTER CHROMATID EXCHANGE;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0345708222     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.07.012     Document Type: Review

References (88)

1. International Agency for Research on Cancer. Chlorinated drinking-water chlorination by-products some other halogenated compounds cobalt and cobalt compounds. IARC Monogr Eval Carcinog Risks Hum 1991; 52:1-544.
2. Lison D., De Boeck M., Verougstraete V., Kirsch-Volders M. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup. Environ. Med. 58(10):2001;619-625.
3. Leonard A., Lauwerys R. Mutagenicity, carcinogenicity and teratogenicity of cobalt metal and cobalt compounds. Mutation Res. 239(1):1990;17-27.
4. Agency for Toxic Substances and Disease Registry. Toxicological profile for cobalt. 2001.
5. Beyersmann D., Hartwig A. The genetic toxicology of cobalt. Toxicol. Appl. Pharmacol. 115(1):1992;137-145.
6. Robison S.H., Cantoni O., Costa M. Strand breakage and decreased molecular weight of DNA induced by specific metal compounds. Carcinogenesis. 3(6):1982;657-662.
7. Nackerdien Z., Kasprzak K.S., Rao G., Halliwell B., Dizdaroglu M. Nickel(II)- and cobalt(II)-dependent damage by hydrogen peroxide to the DNA bases in isolated human chromatin. Cancer Res. 51(21):1991;5837-5842.
8. Kawanishi S., Inoue S., Yamamoto K. Active oxygen species in DNA damage induced by carcinogenic metal compounds. Environ. Health Perspect. 102(Suppl 3):1994;17-20.
9. Lloyd D.R., Phillips D.H., Carmichael P.L. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem. Res. Toxicol. 10(4):1997;393-400.
10. 2 in the presence of chelators in relation to DNA damage and 2′-deoxyguanosine hydroxylation. J. Toxicol. Environ. Health. 47(1):1996;61-75.
11. Sarkar B. Metal replacement in DNA-binding zinc finger proteins and its relevance to mutagenicity and carcinogenicity through free radical generation. Nutrition. 11(Suppl 5):1995;646-649.
12. Anard D., Kirsch-Volders M., Elhajouji A., Belpaeme K., Lison D. In vitro genotoxic effects of hard metal particles assessed by alkaline single cell gel and elution assays. Carcinogenesis. 18(1):1997;177-184.
13. De Boeck M., Lison D., Kirsch-Volders M. Evaluation of the in vitro direct and indirect genotoxic effects of cobalt compounds using the alkaline comet assay, Influence of interdonor and interexperimental variability. Carcinogenesis. 19(11):1998;2021-2029.
14. Van Goethem F., Lison D., Kirsch-Volders M. Comparative evaluation of the in vitro micronucleus test and the alkaline single cell gel electrophoresis assay for the detection of DNA damaging agents: genotoxic effects of cobalt powder. Mutat Res. 392(1-2):1997;31-43.
15. De Boeck M., Lombaert N., De Backer S., Finsy R., Lison D., Kirsch-Volders M. In vitro genotoxic effects of different combinations of cobalt and metallic carbide particles. Mutagenesis. 18(2):2003a;177-186.
16. Lison D., Carbonnelle P., Mollo L., Lauwerys R., Fubini B. Physicochemical mechanism of the interaction between cobalt metal and carbide particles to generate toxic activated oxygen species. Chem. Res. Toxicol. 8(4):1995;600-606.
17. Hartwig A., Snyder R.D., Schlepegrell R., Beyersmann D. Modulation by Co(II) of UV-induced DNA repair, mutagenesis and sister-chromatid exchanges in mammalian cells. Mutation Res. 248(1):1991;177-185.
18. Yokoiyama A., Kada T., Kuroda Y. Antimutagenic action of cobaltous chloride on radiation-induced mutations in cultured Chinese hamster cells. Mutat Res. 245(2):1990;99-105.
19. Kasten U., Mullenders L.H., Hartwig A. Cobalt(II) inhibits the incision and the polymerization step of nucleotide excision repair in human fibroblasts. Mutat Res. 383(1):1997;81-89.
20. Asmuss M., Mullenders L.H., Eker A., Hartwig A. Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis. 21(11):2000;2097-2104.
21. Palecek E., Brazdova M., Cernocka H., Vlk D., Brazda V., Vojtesek B. Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments. Oncogene. 18(24):1999;3617-3625.
22. Méplan C., Richard M.J., Hainaut P. Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene. 19(46):2000;5227-5236.
23. Resende de Souza-Nazareth H. Efeito do cloreto de cobalto em ao-disjunçao. Cience e Cultura. 28(12):1976;1472-1475.
24. Lison D., Lauwerys R. The interaction of cobalt metal with different carbides and other mineral particles on mouse peritoneal macrophages. Toxicol vitro. 9(3):1995;341-347.
25. Costa M., Heck J.D., Robison S.H. Selective phagocytosis of crystalline metal sulfide particles and DNA strand breaks as a mechanism for the induction of cellular transformation. Cancer Res. 42(7):1982;2757-2763.
26. Miller A.C., Mog S., McKinney L., Luo L., Allen J., Xu J., Page N. Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects. Carcinogenesis. 22(1):2001;115-125.
27. Zou W., Yan M., Xu W., Huo H., Sun L., Zheng Z., Liu X. Cobalt chloride induces PC12 cells apoptosis through reactive oxygen species and accompanied by AP-1 activation. J. Neurosci. Res. 64(6):2001;646-653.
28. Zou W., Zeng J., Zhuo M., Xu W., Sun L., Wang J., Liu X. Involvement of caspase-3 and p38 mitogen-activated protein kinase in cobalt chloride-induced apoptosis in PC12 cells. J. Neurosci. Res. 67(6):2002;837-843.
29. Wätjen W., Cox M., Biagioli M., Beyersmann D. Cadmium-induced apoptosis in C6 glioma cells: mediation by caspase 9-activation. Biometals. 15(1):2002;15-25.
30. Araya J., Maruyama M., Inoue A., Fujita T., Kawahara J., Sassa K., Hayashi R., Kawagishi Y., Yamashita N., Sugiyama E., Kobayashi M. Inhibition of proteasome activity is involved in cobalt-induced apoptosis of human alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 283(4):2002;L849-L858.
31. 2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann. N.Y. Acad. Sci. 973:2002;443-447.
32. Catelas I., Petit A., Zukor D.J., Antoniou J., Huk O.L. TNF-alpha secretion and macrophage mortality induced by cobalt and chromium ions in vitro - qualitative analysis of apoptosis. Biomaterials. 24(3):2003;383-391.
33. Kasprzak K.S., Zastawny T.H., North S.L., Riggs C.W., Diwan B.A., Rice J.M., Dizdaroglu M. Oxidative DNA base damage in renal, hepatic, and pulmonary chromatin of rats after intraperitoneal injection of cobalt(II) acetate. Chem. Res. Toxicol. 7(3):1994;329-335.
34. Goldwasser E., Jacobson L.O., Fried W.et al. Studies on erythropoiesis. V. The effect of cobalt on the production of erythropoietin. Blood. 13:1958;55-60.
35. Suzuki Y., Shimizu H., Nagae Y., Fukumoto M., Okonogi H., Kadokura M. Micronucleus test and erythropoiesis: effect of cobalt on the induction of micronuclei by mutagens. Environ. Mol. Mutagen. 22(2):1993;101-106.
36. M. De Boeck, P. Hoet, N. Lombaert, B. Nemery, M. Kirsch-Volders, D. Lison, In vivo genotoxicity of hard metal dust: induction of micronuclei in rat type II epithelial lung cells. Carcinogenesis 2003b, in press.
37. Farah S.B. The in vivo effect of cobalt chloride on chromosomes. Rev. Brasil. Genet. VI. 3:1983;433-442.
38. Palit S., Sharma A., Talukder G. Chromosomal aberrations induced by cobaltous chloride in mice in vivo. Biol. Trace Elem. Res. 29(2):1991;139-145.
39. Gennart J.P., Baleux C., Verellen-Dumoulin C., Buchet J.P., De Meyer R., Lauwerys R. Increased sister chromatid exchanges and tumour markers in workers exposed to elemental chromium-, cobalt- and nickel-containing dusts. Mutat Res. 299(1):1993;55-61.
40. Stea S., Visentin M., Granchi D., Savarino L., Dallari D., Gualtieri G., Rollo G., Toni A., Pizzoferrato A., Montanaro L. Sister chromatid exchange in patients with joint prostheses. J. Arthroplasty. 15(6):2000;772-777.
41. De Boeck M., Lardau S., Buchet J.P., Kirsch-Volders M., Lison D. Absence of significant genotoxicity in lymphocytes and urine from workers exposed to moderate levels of cobalt-containing dust: a cross-sectional study. Environ. Mol. Mutagen. 36(2):2000;151-160.
42. Moulin J.J., Wild P., Romazini S., Lasfargues G., Peltier A., Bozec C., Deguerry P., Pellet F., Perdrix A. Lung cancer risk in hard-metal workers. Am. J. Epidemiol. 148(3):1998;241-248.
43. 2) in rats. Lab. Anim. 11(1):1977;43-46.
44. Lewis C.G., Belniak R.M., Plowman M.C., Hopfer S.M., Knight J.A., Sunderman F.W. Jr. Intraarticular carcinogenesis bioassays of CoCrMo and TiAlV alloys in rats. J. Arthroplasty. 10(1):1995;75-82.
45. Bucher J.R., Hailey J.R., Roycroft J.R., Haseman J.K., Sills R.C., Grumbein S.L., Mellick P.W., Chou B.J. Inhalation toxicity and carcinogenicity studies of cobalt sulfate. Toxicol. Sci. 49(1):1999;56-67.
46. Borm P.J., Driscoll K. Particles, inflammation and respiratory tract carcinogenesis. Toxicol. Lett. 88(1-3):1996;109-113.
47. Driscoll K.E., Costa D.L., Hatch G., Henderson R., Oberdorster G., Salem H., Schlesinger R.B. Intratrachel instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol. Sci. 55:2000;24-35.
48. Mur J.M., Moulin J.J., Charruyer-Seinerra M.P., Lafitte J. A cohort mortality study among cobalt and sodium workers in an electrochemical plant. Am. J. Ind. Med. 11(1):1987;75-81.
49. Moulin J.J., Wild P., Mur J.M., Fournier-Betz M., Mercier-Gallay M. A mortality study of cobalt production workers: an extension of the follow-up. Am. J. Ind. Med. 23(2):1993;281-288.
50. Hogstedt C., Alexandersson R. Mortality study among workers from the hard metal industry. Arbete och Hälsa. 21:1990;1-20.
51. Lasfargues G., Wild P., Moulin J.J., Hammon B., Rosmorduc B., Rondeau du Noyer C., Lavandier M., Moline J. Lung cancer mortality in a French cohort of hard-metal workers. Am. J. Ind. Med. 26(5):1994;585-595.
52. Wild P., Perdrix A., Romazini S., Moulin J.J., Pellet F. Lung cancer mortality in a site producing hard metals. Occup. Environ. Med. 57(8):2000;568-573.
53. Dieter M.P., Jameson C.W., Elwell M.R., Lodge J.W., Hejtmancik M., Grumbein S.L., Ryan M., Peters A.C. Comparative toxicity and tissue distribution of antimony potassium tartrate in rats and mice dosed by drinking water or intraperitoneal injection. J. Toxicol. Environ. Health. 34(1):1991;51-82.
54. Sereno D., Holzmuller P., Mangot I., Cuny G., Ouaissi A., Lemesre J.L. Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob. Agents Chemother. 45(7):2001;2064-2069.
55. Gebel T. Arsenic and antimony: comparative approach on mechanistic toxicology. Chem. Biol. Interact. 107(3):1997;131-144.
56. Gebel T. Suppression of arsenic-induced chromosome mutagenicity by antimony. Mutat Res. 412(3):1998;213-218.
57. Li X., Thornton I. Arsenic, antimony and bismuth in soil and pasture herbage in some old metalliferous mining areas in England. Environ. Geochem. Health. 15:1993;135-144.
58. Gebel T., Kevekordes S., Schaefer J., von Platen H., Dunkelberg H. Assessment of a possible genotoxic environmental risk in sheep bred on grounds with strongly elevated contents of mercury, arsenic and antimony. Mutat Res. 368(3-4):1996;267-274.
59. Gebel T., Christensen S., Dunkelberg H. Comparative and environmental genotoxicity of antimony and arsenic. Anticancer Res. 17(4A):1997;2603-2607.
60. International Agency for Research on Cancer. Overall evaluations of carcinogenicity: an updating of IARC Monographs, vols. 1-42. IARC Monogr. Eval. Carcinog. Risks Hum. Suppl. 1987;7:1-440.
61. International Agency for Research on Cancer. Some Organic Solvents, Resin Monomers and Related Compounds, Pigments and Occupational Exposures in Paint Manufacture and Painting. IARC Monogr. Eval. Carcinog. Risks Hum. 1989;47:1-535.
62. Frank C., Mohamed M.K., Strickland G.T., Lavancy D., Arthur R.R., Magder L.S., El Khoby T., Abdel-Wahab Y., Aly Ohn E.S., Anwar W., Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 355:2000;887-981.
63. Tirmenstein M.A., Plews P.I., Walker C.V., Woolery M.D., Wey H.E., Toraason M.A. Antimony-induced oxidative stress and toxicity in cultured cardiac myocytes. Toxicol. Appl. Pharmacol. 130(1):1995;41-47.
64. Agency for Toxic Substances and Disease Registry. Toxicological profile for antimony and compounds. 1992.
65. Leonard A., Gerber G.B. Mutagenicity, carcinogenicity and teratogenicity of antimony compounds. Mutat Res. 366(1):1996;1-8.
66. Kuroda K., Endo G., Okamoto A., Yoo Y.S., Horiguchi S. Genotoxicity of beryllium, gallium and antimony in short-term assays. Mutat Res. 264(4):1991;163-170.
67. Lantzsch H., Gebel T. Genotoxicity of selected metal compounds in the SOS chromotest. Mutat Res. 389(2-3):1997;191-197.
68. Elliott B.M., Mackay J.M., Clay P., Ashby J. An assessment of the genetic toxicology of antimony trioxide. Mutat Res. 415(1-2):1998;109-117.
69. Knasmuller S., Gottmann E., Steinkellner H., Fomin A., Pickl C., Paschke A., Göd R., Kundi M. Detection of genotoxic effects of heavy metal contaminated soils with plant bioassays. Mutat Res. 420(1-3):1998;37-48.
70. Schaumloffel N., Gebel T. Heterogeneity of the DNA damage provoked by antimony and arsenic. Mutagenesis. 13(3):1998;281-286.
71. Gebel T., Birkenkamp P., Luthin S., Dunkelberg H. Arsenic(III), but not antimony(III), induces DNA-protein crosslinks. Anticancer Res. 18(6A):1998;4253-4257.
72. Huang H., Shu S.C., Shih J.H., Kuo C.J., Chiu I.D. Antimony trichloride induces DNA damage and apoptosis in mammalian cells. Toxicology. 129(2-3):1998;113-123.
73. Migliore L., Cocchi L., Nesti C., Sabbioni E. Micronuclei assay and FISH analysis in human lymphocytes treated with six metal salts. Environ. Mol. Mutagen. 34(4):1999;279-284.
74. Takahashi S., Sato H., Kubota Y., Utsumi H., Bedford J.S., Okayasu R. Inhibition of DNA-double strand break repair by antimony compounds. Toxicology. 180(3):2002;249-256.
75. Lecureur V., Lagadic-Gossmann D., Fardel O. Potassium antimonyl tartrate induces reactive oxygen species-related apoptosis in human myeloid leukemic HL60 cells. Int. J. Oncol. 20(5):2002;1071-1076.
76. Lecureur V., Le Thiec A., Le Meur A., Amiot L., Drenou B., Bernard M., Lamy T., Fauchet R., Fardel O. Potassium antimonyl tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cells. Br. J. Haematol. 119(3):2002;608-615.
77. Gurnani N., Sharma A., Talukder G. Comparison of the clastogenic effects of antimony trioxide on mice in vivo following acute and chronic exposure. Biometals. 5(1):1992;47-50.
78. Gurnani N., Sharma A., Talukder G. Comparison of clastogenic effects of antimony and bismuth as trioxides on mice in vivo. Biol. Trace Elem. Res. 37(2-3):1993;281-292.
79. Hantson P., Leonard E.D., Crutzen-Fayt M.C., Leonard A., Vandercam B., Delaere B., Mahieu P. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis. Pharmacotherapy. 16(5):1996;869-871.
80. Cavallo D., Iavicoli I., Setini A., Marinaccio A., Perniconi B., Carelli G., Iavicoli S. Genotoxic risk and oxidative DNA damage in workers exposed to antimony trioxide. Environ. Mol. Mutagen. 40(3):2002;184-189.
81. W.D. Watt, Chronic inhalation toxicity of antimony trioxide, validation of the TLV. PhD thesis, Wayne State University, Detroit, MI; 1983.
82. Groth D.H., Stettler L.E., Burg J.R., Busey W.M., Grant G.C., Wong L. Carcinogenic effects of antimony trioxide and antimony ore concentrate in rats. J. Toxicol. Environ. Health. 18(4):1986;607-626.
83. Newton P.E., Bolte H.F., Daly I.W., Pillsbury B.D., Terrill J.B., Drew R.T., Ben-Dyke R., Sheldon A.W., Rubin L.F. Subchronic and chronic inhalation toxicity of antimony trioxide in the rat. Fundam. Appl. Toxicol. 22(4):1994;561-576.
84. Wingren G., Axelson O. Epidemiologic studies of occupational cancer as related to complex mixtures of trace elements in the art glass industry. Scand. J. Work Environ. Health. 19(Suppl 1):1993;95-100.
85. Potkonjak V., Pavlovich M. Antimoniosis: a particular form of pneumoconiosis. I. Etiology, clinical and X-ray findings. Int. Arch. Occup. Environ. Health. 51(3):1983;199-207.
86. Gerhardsson L., Nordberg G.F. Lung cancer in smelter workers- interactions of metals as indicated by tissue levels. Scand. J. Work Environ. Health. 19(Suppl 1):1993;90-94.
87. Jones R.D. Survey of antimony workers: mortality 1961-1992. Occup. Environ. Med. 51(11):1994;772-776.
88. Schnorr T.M., Steenland K., Thun M.J., Rinsky R.A. Mortality in a cohort of antimony smelter workers. Am. J. Ind. Med. 27(5):1995;759-770.